Targeting breast cancer with a combination of DNT and LAG3 checkpoint blockage and its mechanism.
Miao WangYuhan WeiYingrui LiHongzhong LiJiangtao JinYuting LuQin LiPublished in: Immunity, inflammation and disease (2022)
Our study revealed the suppressive status of TIME in breast cancer and supported DNT cells had the potential to be applied as a novel adoptive cell therapy for TNBC either alone or combined with LAG3Ab.